US Broker Ratings

Merck & Co., Inc. (MRK) Stock Analysis: A 15.94% Potential Upside with Strong Buy Ratings

Merck & Co., Inc. (NYSE: MRK), a cornerstone in the healthcare sector, continues to capture investor attention with its robust pipeline and strategic partnerships. With a..

Atrium Therapeutics, Inc. (RNA): Investor Outlook Highlights 73.49% Upside Potential

Atrium Therapeutics, Inc. (NASDAQ: RNA), a biopharmaceutical innovator specializing in RNA therapeutics for cardiomyopathies, is garnering attention for its promising pipeline and significant upside potential. With..

iRhythm Holdings, Inc. (IRTC) Stock Analysis: Unveiling a 55.60% Potential Upside

For investors keen on the healthcare sector, particularly the medical devices industry, iRhythm Holdings, Inc. (NASDAQ: IRTC) presents an intriguing investment opportunity. With a market capitalization..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Exploring the Future of RNA-Targeted Therapeutics with Promising Forward P/E

For investors keen on the biotechnology sector, Sarepta Therapeutics, Inc. (NASDAQ: SRPT) is a company worth watching due to its cutting-edge research in RNA-targeted therapeutics and..

Nuvalent, Inc. (NUVL) Stock Analysis: Unveiling a 32% Potential Upside in Biotech Innovation

Nuvalent, Inc. (NASDAQ: NUVL), a burgeoning player in the biotechnology sector, is captivating investor interest with its promising pipeline of cancer therapies and a striking analyst..

TG Therapeutics, Inc. (TGTX) Stock Analysis: Exploring a 26% Potential Upside in the Biotech Sector

For investors with a keen eye on the healthcare sector, TG Therapeutics, Inc. (NASDAQ: TGTX) offers an intriguing opportunity. This biopharmaceutical company, with its focus on..

Guardant Health, Inc. (GH) Stock Analysis: Exploring a Potential 42% Upside in the Precision Oncology Market

Guardant Health, Inc. (NASDAQ: GH), a prominent player in the precision oncology sector, is capturing investor attention with a potential upside of 42.06%, according to analyst..

Rhythm Pharmaceuticals (RYTM): Analyst Consensus Suggests 55% Upside Potential for Investors

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) stands at the forefront of the biotechnology sector with a targeted focus on rare neuroendocrine diseases. With a market capitalization of..

Telix Pharmaceuticals Limited (TLX) Stock Analysis: Exploring a 101% Potential Upside in Biotech Innovation

Telix Pharmaceuticals Limited (TLX), a prominent player in the biotechnology sector, is making waves with its innovative approach to radiopharmaceuticals. With a market cap of $3.64..

Legend Biotech Corporation (LEGN): Analyst Consensus Reveals 170% Potential Upside

Legend Biotech Corporation (NASDAQ: LEGN) is a notable player in the biotechnology sector, positioning itself at the forefront of innovative cancer treatments. Headquartered in Somerset, New..

Bausch + Lomb Corporation (BLCO)

⚠️ No article content returned.

..

Roivant Sciences Ltd. (ROIV)

⚠️ No article content returned.

..

Glaukos Corporation (GKOS) Stock Analysis: A Medical Device Innovator with 11.32% Potential Upside

Glaukos Corporation (NYSE: GKOS), a pioneering name in the healthcare sector, specifically within the medical devices industry, is making waves with its innovative solutions targeting glaucoma,..

Corcept Therapeutics (CORT) Stock Analysis: Exploring a 46% Upside Potential in the Biotech Sector

For investors seeking opportunities in the biotech sector, Corcept Therapeutics Incorporated (CORT) presents a compelling case with its current market dynamics and growth prospects. Specializing in..

TransMedics Group, Inc. (TMDX) Stock Analysis: Exploring a 33.77% Potential Upside in Medical Device Innovation

TransMedics Group, Inc. (NASDAQ: TMDX), a pivotal player in the healthcare sector, specifically within the medical devices industry, is garnering attention with its innovative approach to..

Lantheus Holdings, Inc. (LNTH)

⚠️ No article content returned.

..

Krystal Biotech, Inc. (KRYS) Stock Analysis: Unveiling a Promising 14.51% Upside Potential for Investors

Krystal Biotech, Inc. (NASDAQ: KRYS), a trailblazer in the biotechnology sector, has caught the attention of investors with its focus on developing genetic medicines for conditions..

Labcorp Holdings Inc. (LH) Stock Analysis: Evaluating a 14.55% Potential Upside for Investors

Labcorp Holdings Inc. (NYSE: LH) stands as a formidable player in the healthcare sector, specifically within the diagnostics and research industry. Headquartered in Burlington, North Carolina,..

Align Technology, Inc. (ALGN)

⚠️ No article content returned.

..

Cytokinetics, Inc. (CYTK) Stock Analysis: A 39% Potential Upside in the Biotech Arena

Cytokinetics, Incorporated (NASDAQ: CYTK) stands as a compelling player in the biotechnology sector, primarily focusing on pioneering treatments for debilitating muscular and cardiac diseases. As the..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds